Skip to Main Content
Donate

This is a test.

Ensuring progress continues for generations to come

This is a test.

Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources

This is a test.

Advocacy in action: Making game-changing PARP Inhibitors accessible for women in Prince Edward Island

This is a test.

Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world

This is a test.

CEO Blog: It’s time to be bold

This is a test.

Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative

This is a test.

Clinical Trial: New biomarkers, improved treatment pathways

This is a test.

Volunteers recognized for their impact: The Peggy Truscott Award of Hope

This is a test.

Research knows no bounds

This is a test.

Learning and Connecting – 2022 National Symposium